<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-103 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-103</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-103</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-2.html">extraction-schema-2</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <p><strong>Paper ID:</strong> paper-70849336</p>
                <p><strong>Paper Title:</strong> Rate of EGFR mutation in patients with pulmonary adenocarcinoma</p>
                <p><strong>Paper Abstract:</strong> Purpose: Contemporary literature on lung adenocarcinoma has demonstrated a genetic difference of the epidermal growth factor receptor (EGFR) pathway conferring to ethnicity, such as higher frequency of activated EGFR mutations in East Asian population. This information is missing in some developing countries, and we intend to address this gap in the literature. Methods: We examined the rate of EGFR mutations among Pakistani patients with adenocarcinoma of the lung. Fine-needle aspiration samples were gathered from 73 patients. Polymerase chain reaction was performed on extracted DNA for mutational analysis of EGFR exons 19 and 21. Results: EGFR mutations were discovered in 18 of 73 (24.6%) patients. We did not find any significant difference in EGFR mutation rate with regard to patient's age, sex, smoking history, clinical stage of lung cancer, subtypes of adenocarcinoma, and tumor differentiation. Conclusion: Our investigation shows that the EGFR mutation rate in our patient population with adenocarcinoma of the lung was higher than in African-American, Arabian, and white Caucasian patients, and was lower than the East Asian population.</p>
                <p><strong>Cost:</strong> 0.015</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e103.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e103.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Pakistan (study)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Pakistani patients with pulmonary adenocarcinoma (Karachi cohort)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Single-center study of 73 Pakistani patients with pulmonary adenocarcinoma (CT-guided FNA samples) tested for EGFR exon 19 and 21 mutations; reports overall and exon-specific frequencies and analyses vs clinicopathologic features.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Pakistani patients with pulmonary adenocarcinoma (recruited at KIRAN/AEMC, JPMC, Karachi, 2011-2013)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>24.6% overall (18/73); exon 19 mutations 15% (11/73); exon 21 mutations 9.5% (7/73)</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Qualitative comparisons made in paper: Pakistani rate higher than African-American, Arabian, and white Caucasian patients; lower than East Asian populations and other countries of South Asia (no numeric frequencies for those groups provided in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td>Exon 19 deletions and exon 21 L858R (study assayed exons 19 and 21; paper notes ~90% of classical activating mutations are exon 19 deletions or exon 21 L858R).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td>No statistically significant association found in this cohort; mutation rates by smoking status reported as never-smoker 26% (7/27), former-smoker 33.3% (4/12), current-smoker 20.5% (7/34).</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td>None specific proposed; paper states the influence of ethnicity on EGFR mutation rate is poorly understood and attributes differences to 'fundamental differences between cohorts' without molecular mechanism.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Pulmonary adenocarcinoma (a subtype of non-small cell lung cancer)</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td>Median age 58.9 (range 18â€“84); male:female distribution in cohort 53:20; mutation frequency by sex: males 26.4% (14/53), females 20% (4/20); no significant differences by age or stage found.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Authors propose that observed ethnic/geographic differences may reflect fundamental differences between cohorts and possible bias from stage at diagnosis; specifically, late-stage presentation in Pakistan (due to lack of mandatory national health insurance) may affect observed mutation rates.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td>Small sample size (n=73) limits conclusions; single-center sampling though major cancer center; late-stage presentation of patients in Pakistan could confound cross-ethnic comparisons; authors state sample size insufficient to draw definitive conclusions.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e103.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>East Asian</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>East Asian populations (patients with NSCLC/adenocarcinoma)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Described in the paper (literature) as having higher EGFR mutation frequencies compared with non-Asian populations; cited value provided in introduction.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>East Asian patients with non-small cell lung cancer (general literature reference)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Approximately 35% overall (value cited in the paper's introduction).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Higher than US (~10%) and higher than Pakistani cohort (24.6%); paper explicitly states East Asian mutation frequency exceeds that seen in Pakistani patients.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td>Classical activating EGFR mutations predominantly exon 19 deletions and exon 21 L858R (~90% of classical mutations, as noted in paper).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td>Paper references literature indicating classical EGFR mutations are predictive of response to EGFR-TKI in East Asian populations; general literature associates EGFR mutations more commonly with never-smokers, but no detailed East-Asian-specific smoking breakdown is provided here.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td>Not specified in this paper; authors state the influence of ethnicity on mutation rate is poorly understood.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Non-small cell lung cancer / adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>No molecular explanation provided here beyond 'fundamental differences between cohorts' and incomplete understanding of ethnicity effects.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e103.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>United States (US)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>United States (patients with non-small cell lung cancer)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Cited as an example of a non-Asian population with lower reported EGFR mutation frequency in NSCLC compared with East Asian populations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>US patients with non-small cell lung cancer (general literature reference)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Nearly 10% overall (value cited in the paper's introduction).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Lower than East Asian (~35%) and lower than the Pakistani cohort reported here (24.6%).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td>Exon 19 deletions and exon 21 L858R are cited as the predominant classical mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td>Paper references literature noting EGFR mutations are common in 'never smokers' (cited references), but no US-specific breakdown is provided in the study.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td>Not specified.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Not specified in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e103.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>African-American</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>African-American patients with non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Referenced in discussion as a population in which EGFR mutation frequency is reported to be lower than the Pakistani cohort; a specific cited study on EGFR pathway abnormalities in African Americans is listed in references.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>African-American patients with non-small cell lung cancer (literature reference)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Paper states Pakistani EGFR mutation rate is higher than that reported for African-American patients, but provides no numeric frequency in-text.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Not specified in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e103.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Arabian / Middle East</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Arabian / Middle Eastern lung cancer populations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Paper indicates Pakistani rate is higher than Arabian patients; references a Middle East study reporting high EGFR amplification rate but low mutation frequency.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Middle Eastern / Arabian patients with lung cancer (literature reference)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Paper reports Pakistani frequency higher than Arabian (Middle Eastern) populations; one cited Middle Eastern study described high EGFR amplification but low mutation frequency (no numeric percent reported in this text).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Lung cancer (unspecified subtype in the referenced study description)</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Not specified.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e103.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>White Caucasian</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>White Caucasian patients with non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Referenced as a non-Asian population with lower EGFR mutation frequency than reported in the Pakistani cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>White Caucasian patients with NSCLC (literature reference)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Paper states Pakistani EGFR mutation rate is higher than that reported in white Caucasian patients; no numeric frequency provided here (US ~10% cited elsewhere).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td>Exon 19 deletions and exon 21 L858R are noted generally as the dominant classical mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Not specified.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e103.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Other South Asia</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Other South Asian countries' lung cancer populations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Paper states that EGFR mutation frequency in Pakistan was lower than reported in East Asia and other countries of South Asia (a citation to an Indian screening study is listed).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Other South Asian country populations with lung cancer (e.g., India as cited)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Paper reports Pakistan < other South Asian countries (no numerical values provided in this text).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Lung cancer / adenocarcinoma (contextual)</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Not specified.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e103.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e103.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Never-smokers (risk factor)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Never-smoker lung cancer patients (association with EGFR mutations)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Paper (and its references) note that EGFR mutations are common in lung cancers from never-smokers and are associated with sensitivity to EGFR TKIs; in this Pakistani cohort, no statistically significant association was observed.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Never-smoker lung cancer patients (general literature plus cohort data in this paper)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>General literature indicates higher EGFR mutation prevalence among never-smokers; in this paper's Pakistani cohort, never-smokers had a 26% mutation rate (7/27) but this was not statistically different from smokers/former-smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td>Classical EGFR activating mutations (exon 19 deletions, exon 21 L858R) are often reported in never-smokers according to cited literature.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td>Literature: EGFR mutations common in never-smokers; This study: no significant association between smoking status and mutation presence (never 26%, former 33.3%, current 20.5%).</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td>Not detailed in this paper beyond literature citation that links never-smoker status with EGFR mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Adenocarcinoma / NSCLC</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>Paper does not propose a mechanism explaining the never-smoker association; references older studies documenting the observation.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td>In this cohort the lack of statistical association suggests either no strong effect in this sample or insufficient power; smoking history distribution and sample size could confound detection.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors <em>(Rating: 2)</em></li>
                <li>Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer <em>(Rating: 2)</em></li>
                <li>High epidermal growth factor receptor amplification rate but low mutation frequency in Middle East lung cancer population <em>(Rating: 2)</em></li>
                <li>Screening for EGFR mutations in lung cancer, a report from India <em>(Rating: 2)</em></li>
                <li>Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma <em>(Rating: 2)</em></li>
                <li>EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. <em>(Rating: 1)</em></li>
                <li>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. <em>(Rating: 1)</em></li>
                <li>Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>